XTX Topco »

Brainstorm Cell Therapeutics shares owned by XTX Topco

Quarter-by-quarter ownership of Brainstorm Cell Therapeutics (BCLI) shares owned by XTX Topco from 13F filings

Historical chart of XTX Topco investment in Brainstorm Cell Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Brainstorm Cell Therapeutics held by XTX Topco consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Brainstorm Cell Therapeutics by XTX Topco

Quarter filed Position value Share count Share price at filing
2023-09-30 $4.9k 25k 0.20
2023-03-31 $40k 12k 3.30

More positions owned by XTX Topco

Eli Lilly & Co. (LLY)
Anthem (ELV)
IDEXX Laboratories (IDXX)
Activision Blizzard
W.W. Grainger (GWW)
Visa Com Cl A (V)
TransDigm Group Incorporated (TDG)
Vertex Pharmaceuticals Incorporated (VRTX)
Microsoft Corporation (MSFT)
Cummins (CMI)
Nike CL B (NKE)
American Express Company (AXP)
Hf Sinclair Corp (DINO)
Deckers Outdoor Corporation (DECK)
Automatic Data Processing (ADP)

View all positions for XTX Topco

Top funds holding Brainstorm Cell Therapeutics

Vanguard Group
Liberty Wealth Management
Weaver Consulting Group
Caldwell Sutter Capital
Abner, Herrman & BrocK
Raymond James & Associates
ADAR1 Capital Management
Ikarian Capital
Kingswood Wealth Advisors
Citadel Advisors
Virtu Financial
Jmac Enterprises
Barclays
Wells Fargo & Company
Saxony Capital Management

View all funds holding Brainstorm Cell Therapeutics